Jun 2026 (Q2 FY26) — Aug 4, 2026
Certara Q2 FY26 — Strategic Realignment and AI Integration Drive Software Momentum
Read the full callCertara (CERT) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Certara earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 93.3 | +1.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -0.2 | −8.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -55.3 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$9.45 +0.85% · +$0.08
Performance −21.1% 1Y
1Y: $11.97 on 17 Oct 2025 → $9.45. High $12.72 (22 Oct 2025), low $4.48 (15 May 2026).
- Previous close
- $9.37
- 52-week range
- $4.48 – $12.72
- One year
- −23.23%
Overview
- Symbol
- CERT
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Certara earnings calls (CERT)
Financials
What the filings say
Net profit, year on year: −2708% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 95 | 100 | 106 | 92 | 105 | 104 | 107 | 93 |
| Operating profit | 3 | 6 | 8 | 8 | 3 | 1 | -4 | -0 |
| Operating margin | 2.7% | 6.0% | 7.2% | 8.3% | 2.9% | 0.8% | −4.0% | −0.2% |
| Other income | -4 | -4 | -3 | -3 | -3 | -4 | -4 | -6 |
| Interest | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | -2 | 2 | 5 | 4 | -0 | -3 | -8 | -6 |
| Tax rate | 17.5% | −201.7% | −4.4% | 65.8% | 671.2% | −102.6% | −10.3% | 4.8% |
| Net profit | -1 | 7 | 5 | -2 | 2 | -6 | -9 | -55 |
| EPS ($ per share) | -0.01 | — | 0.03 | -0.01 | 0.01 | — | -0.06 | -0.36 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 2 | 2 | 2 | — | — | — |
| Reserves | — | -62 | -76 | -61 | -116 | -128 | -130 |
| Total liabilities | — | 447 | 470 | 493 | 516 | 516 | 494 |
| Fixed assets | — | 4 | 3 | 2 | 3 | 2 | 2 |
| Total assets | — | 1,269 | 1,512 | 1,573 | 1,563 | 1,575 | 1,557 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 38 | 45 | 60 | 93 | 83 | 80 | 96 |
| Cash from investing | -10 | -9 | -270 | -28 | -80 | -112 | -27 |
| Cash from financing | -8 | 208 | 123 | -7 | -9 | -21 | -64 |
| Net cash flow | 18 | 244 | -87 | 53 | -5 | -56 | 10 |
| Capital expenditure | -2 | -1 | -1 | -1 | -2 | -2 | -2 |
| Free cash flow | 36 | 44 | 59 | 91 | 81 | 79 | 95 |
Insider filings
47 filings between Nov 11, 2025 and Jun 1, 2026.
Open market
decisions to buy or sellPurchases
$200.0K
1 purchase by 1 insider
Sales
None
No insider sold shares.
Compensation
not trading decisions- 3
- Award — granted as compensation
- 24
- Option exercise — converted options into shares
- 19
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Feehery William F | $200.0K | — | Nov 11, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | Anhalt Rona Chief Human Resources Officer | Option exercise | 7,147 | $0 |
| Jun 1, 2026 | Anhalt Rona Chief Human Resources Officer | Tax withheld | 2,241 | $13.0K |
| Jun 1, 2026 | Corcoran Daniel SVP and General Counsel | Option exercise | 7,941 | $0 |
| Jun 1, 2026 | Corcoran Daniel SVP and General Counsel | Tax withheld | 4,210 | $24.5K |
| Jun 1, 2026 | Corcoran Daniel SVP and General Counsel | Option exercise | 14,889 | $0 |
| Jun 1, 2026 | Corcoran Daniel SVP and General Counsel | Tax withheld | 7,893 | $45.9K |
| May 14, 2026 | Killefer Nancy Director | Option exercise | 15,757 | $0 |
| May 14, 2026 | CASHMAN JAMES E III Director | Option exercise | 15,757 | $0 |
| May 14, 2026 | BROSHY ERAN Director | Option exercise | 15,757 | $0 |
| May 14, 2026 | WALSH MATTHEW M Director | Option exercise | 15,757 | $0 |
| May 14, 2026 | Collins Cynthia Director | Option exercise | 15,757 | $0 |
| May 14, 2026 | Crane Rosemary A Director | Option exercise | 15,757 | $0 |
| May 14, 2026 | Reynders John V W Chief Financial Officer | Option exercise | 15,757 | $0 |
| May 14, 2026 | Bedi Arjun Director | Option exercise | 5,547 | $0 |
| May 11, 2026 | Resnick Jon Matthew Chief Executive Officer | Option exercise | 59,766 | $0 |
| May 11, 2026 | Resnick Jon Matthew Chief Executive Officer | Tax withheld | 24,377 | $153.8K |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Award | 14,510 | $0 |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Tax withheld | 3,534 | $20.1K |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Option exercise | 7,852 | $0 |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Tax withheld | 1,912 | $10.9K |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Option exercise | 10,127 | $0 |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Tax withheld | 2,466 | $14.1K |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Option exercise | 15,188 | $0 |
| Apr 1, 2026 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Tax withheld | 3,699 | $21.1K |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Award | 23,346 | $0 |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Tax withheld | 7,775 | $44.3K |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Option exercise | 12,633 | $0 |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Tax withheld | 4,327 | $0 |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Option exercise | 15,190 | $0 |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Tax withheld | 5,203 | $29.7K |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Option exercise | 22,782 | $0 |
| Apr 1, 2026 | Gallagher John E Chief Financial Officer | Tax withheld | 7,803 | $44.5K |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Award | 14,510 | $0 |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Tax withheld | 6,821 | $38.9K |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Option exercise | 7,852 | $0 |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Tax withheld | 3,691 | $21.0K |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Option exercise | 10,127 | $0 |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Tax withheld | 4,760 | $27.1K |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Option exercise | 15,188 | $0 |
| Apr 1, 2026 | Aspbury Robert PRESIDENT, PREDICTIVE TECH | Tax withheld | 7,139 | $40.7K |
| Apr 1, 2026 | Anhalt Rona Chief Human Resources Officer | Option exercise | 9,764 | $0 |
| Apr 1, 2026 | Anhalt Rona Chief Human Resources Officer | Tax withheld | 3,062 | $17.5K |
| Apr 1, 2026 | Corcoran Daniel SVP and General Counsel | Option exercise | 10,849 | $0 |
| Apr 1, 2026 | Corcoran Daniel SVP and General Counsel | Tax withheld | 5,751 | $32.8K |
| Apr 1, 2026 | McKemey Adrian President, Drug Dev. Solutions | Option exercise | 10,849 | $0 |
| Apr 1, 2026 | McKemey Adrian President, Drug Dev. Solutions | Tax withheld | 2,642 | $15.1K |
| Nov 11, 2025 | Feehery William F CHIEF EXECUTIVE OFFICER | Purchase | 24,096 | $200.0K |
| Sep 9, 2025 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Sale 10b5-1 plan | 51,224 | $559.4K |
| May 30, 2025 | Corcoran Daniel SVP and General Counsel | Option exercise | 7,940 | $0 |
| May 30, 2025 | Corcoran Daniel SVP and General Counsel | Tax withheld | 2,298 | $26.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Certara, Inc.
Free account. Everything above stays public.
Write why you follow Certara, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading